PT Semen Indonesia (Persero) Tbk recorded a growth in financial performance in the first semester of 2013 increased compared to the same period last year. Recorded a net profit of Rp 2.58 trillion or Rp 436 per share, an increase of 22.9 percent.
Semen Indonesia President Director Dwi Soetjipto said Indonesian Cement net profit growth in line with the achievement of revenue, which stood at Rp 11.4 trillion, an increase of 31.9 percent over the same period last year, which stood at Rp 8.6 trillion.
“Revenue is supported by the total cement sales volume stood at 12.23 million tons, an increase of 18.3 percent over the same period last year amounted to 10.32 million tons,” said Dwi in Jakarta, Monday (29/7).
While the national cement sales volumes (industry-red) grew 7.5 percent to 27.83 million tons compared to the previous period, which stood at 25.89 million tonnes. “The increase in sales is outpacing the growth of the Indonesian Cement industry plant operations supported by Tonasa Tuban IV and V and the solid synergies, particularly in the areas of marketing and distribution in the Indonesian Cement Group. So that we are able domestic market share increased to 43.6 percent from 40.9 percent last year, “said Dwi.
Most of the company’s revenue, said Dwi, comes from the domestic market amounted to Rp 10.91 trillion, equivalent to 95.53 percent of total revenue in the first half of this year, an increase of 26.42 percent compared to the position of sales in the same period last year amounting to Rp 8.63 trillion.
In addition to maintaining dominance in the domestic market, Indonesian Cement also continue to boost sales to foreign markets, especially countries in Southeast Asia.
At least, that from January to June this year, Indonesian Cement has achieved record revenues in foreign markets amounted to Rp 511.64 billion. This number is said Dwi jumped nearly 170 percent compared to sales in the first semester abroad last year only amounted to Rp 30.34 billion. “We will continue to expand the market from year to year,” said the man who brought four awards in the SOE Award 2013.
JAKARTA – PT Semen Indonesia (Persero) Tbk said, most of the company’s revenue in the first semester of 2013 was derived from the domestic market. First half of the company’s revenue reached Rp 10.91 trillion, equivalent to 95.53% of total revenue in the first half of this year.
Dwi Soetjipto, President Director of Semen Indonesia, said that the value of domestic sales increased by 26.42% compared to sales in the same period last year of Rp 8.63 trillion.
Of the domestic market, the composition of the Indonesian Cement revenues derived from customers in Java and outside Java almost equal. Java market contributed revenue of Rp 5.72 trillion or 52.43% of total domestic sales. Meanwhile, consumers outside of Java contribute to the revenue of Rp 5.19 trillion or 47.57% of total domestic sales.
In addition to maintaining dominance in the domestic market, Indonesian Cement continues to boost sales to foreign markets, especially countries in Southeast Asia. From January to June this year, Indonesian Cement has achieved record revenues in foreign markets amounted to Rp 511.64 billion.
“This number jumped nearly 170% compared to overseas sales in the first half of last year is only Rp 30.34 billion,” said Dwi
The total home healthcare market in the Americas is expected to reach the value of USD 150.8 billion by 2018 followed by Europe with total revenue of USD 80.5 billion.
The rising need to continuously monitor and care for health has increased the global expenditure on healthcare services and products.
The trend is also gradually pushing people towards home healthcare products and services, due to their cost efficiency and reliability. This, in turn, is driving the growth of the global home healthcare products and services market.
The technological and application developments that have taken place in the home healthcare segment have made them more reliable and globally acceptable. It has also made it feasible for hospitals and patients to get early discharge, and minimize the cost and infrastructure pressures. The growth in certain diseases or medical conditions such as high blood pressure, diabetes, asthma, and other cardiovascular and respiratory diseases, which require continuous monitoring and care, are further driving the home healthcare market growth.
Though the global share of the home healthcare equipment market is considerably less, it is growing at a faster CAGR of 9.9% from 2012 to 2018 due to rising technological innovations, especially in the field of home therapeutic equipment. The home healthcare services market, despite its large share, is expected to grow at a CAGR of 7.4% from 2012 to 2018. The main deterrent, restricting the entry of organized players in this segment is dominance of a large number of small regional players, who are offering their services at low prices, and enjoy high customer loyalty. This has in turn, shifted the attention of big players towards the home healthcare equipment market.
The global home healthcare equipment market can be categorized as: therapeutic equipment market, self-diagnostic and monitoring equipment market, mobility assists equipment market, and others. Currently, the key market players dominating the home healthcare equipment market are: J&J (Johnson and Johnson), Braun, GE Healthcare, Baxter International, Philips Healthcare, Omron Corporation, Invacare, and Medtronic.
The global market for home healthcare services is classified into respiratory therapy, telemetry, rehabilitation services, infusion therapy, and other unskilled home healthcare services. The unskilled healthcare services are provided by individuals such as family members, unlicensed or traditional caretakers, relatives, and friends. The market for home healthcare services is highly organized in regions such as the Americas and Europe, where it is very efficient. A large share, 79.9%, of the global home healthcare services market is dominated by rehabilitation and unskilled care services. However, the segment is believed to be extremely fragmented, and dominated by small and unorganized players.
This research is specially designed to estimate and analyze the demand and performance of home healthcare equipment and services in a global scenario. The research provides in-depth analysis of home healthcare equipment manufacturers, product sales, trend analysis by segments and demand by geography. The report covers all the major application segments of the global home healthcare market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered.